Its theme will be “Progressive MS: Bench to Bedside and Back.”
Multiple Sclerosis News Today covered the last multiple sclerosis event on October 2015: ECTRIMS.
One of the moments of the conference was with Dr. Peter Chin, a renowned neurologist and Principal Medical Director of Global Neuroscience Development at Genentech, a leading biotechnology company and member of the Roche Group, and its exclusive interview with Multiple Sclerosis News Today correspondent Dr. Ana de Barros on the company’s promising multiple sclerosis (MS) therapy ocrelizumab. The new, experimental therapy made headlines that week after the company presented positive data in the treatment of both relapsing and primary progressive multiple sclerosis.
Read all the full ECTRIMS2015 coverage here: http://bit.ly/1MN5Eie